Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Esperion Theraptc (ESPR)

Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Esperion to Participate in Upcoming Piper Sandler 36th Annual Healthcare Conference GlobeNewswire - Thu Nov 21, 7:00AM CST

ESPR : 2.47 (+2.49%)
Esperion Reports 36% Reduction in Major Adverse Limb Events for PAD Patients Treated with Bempedoic Acid at AHA 2024 Quiver Quantitative, Inc. - Mon Nov 18, 7:44PM CST

Bempedoic acid reduces major adverse limb events by 36% in PAD patients unable to take statins, according to new analysis.Quiver AI SummaryEsperion announced that an analysis from the CLEAR Outcomes study...

ESPR : 2.47 (+2.49%)
Esperion Highlights New Exploratory Data from CLEAR Outcomes Trial Highlighting Value of NEXLETOL® (bempedoic acid) in Oral Featured Science Session and Multiple Poster Presentations at AHA Scientific Sessions 2024 GlobeNewswire - Mon Nov 18, 9:30AM CST

ESPR : 2.47 (+2.49%)
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire - Fri Nov 8, 3:15PM CST

ESPR : 2.47 (+2.49%)
Esperion's Q3 Loss Wider Than Expected, Revenues Rise Y/Y
Esperion's Q3 Loss Wider Than Expected, Revenues Rise Y/Y Zacks Investment Research - Thu Nov 7, 11:14AM CST

Esperion Therapeutics, Inc. ESPR incurred a loss of 15 cents per share for the third quarter of 2024, which was wider than the Zacks Consensus Estimate of a loss of 14 cents. The company had incurred a...

FOLD : 9.50 (-0.94%)
ESPR : 2.47 (+2.49%)
CRSP : 46.38 (-1.86%)
LSTA : 2.84 (-2.94%)
Esperion Therapeutics: Q3 Earnings Snapshot AP - Thu Nov 7, 5:08AM CST

Esperion Therapeutics: Q3 Earnings Snapshot

ESPR : 2.47 (+2.49%)
Esperion Reports Third Quarter 2024 Financial Results and Provides a Business Update GlobeNewswire - Thu Nov 7, 5:00AM CST

ESPR : 2.47 (+2.49%)
Esperion to Participate in Upcoming Jefferies London Healthcare Conference GlobeNewswire - Mon Nov 4, 7:00AM CST

ESPR : 2.47 (+2.49%)
Esperion Announces a Featured Presentation in the Late Breaker/Featured Science Track and Three Poster Presentations Accepted for the 2024 American Heart Association (AHA) Scientific Sessions GlobeNewswire - Thu Oct 31, 7:00AM CDT

ESPR : 2.47 (+2.49%)
Esperion to Report Third Quarter 2024 Financial Results on November 7 GlobeNewswire - Thu Oct 24, 7:00AM CDT

ESPR : 2.47 (+2.49%)

Barchart Exclusives

Recent Corn Rally Artificially Propped Up – What’s Next? Barchart - 6 minutes ago
Corn prices appeared to have finally found a bottom from the summer sell-off. Speculators were short the market in record numbers until late August, when they began buying back contracts, convincing some that the harvest seasonal low may be in. Then, exports increased in the last few weeks, and prices rallied more. While the bearish fundamentals of 1.9 billion carry-out and the massive amount of unpriced corn still linger, there isn’t much hope for a significant price rally yet. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot